Evangelia is an innovative healthcare executive with extensive experience establishing, transforming, and scaling pharmaceutical and medical technology companies across Europe. As a CEO and Board Member in the healthcare sector, she has led multiple legal entities spanning Switzerland and Germany, driving business transformation through digital innovation and strategic M&A initiatives.

With a proven track record at global healthcare leaders including Baxter Healthcare and Neuraxpharm, Evangelia has demonstrated expertise in developing strategic market entry approaches and implementing comprehensive digital transformations. Her digital health expertise includes the development and launch of telemedicine platforms designed to bridge healthcare accessibility gaps.

Holding an MBA a BSc in Biotechnology, Evangelia combines scientific knowledge with business acumen. Her board governance expertise, certified by the the Boardroom board program, ensures strategic oversight and responsible corporate governance across her ventures. Multilingual and internationally-minded, she brings a global perspective shaped by professional experience spanning Switzerland, Greece, Italy, Cyprus, and collaboration with partners in the USA and China.